Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Mar 24, 2026; 17(3): 114990
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.114990
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.114990
When to operate pancreatic intraductal papillary mucinous neoplasm: Literature review
Thamer H Alghamdi, Department of Surgery, Al-Baha University, Al Baha 65716, Saudi Arabia
Author contributions: Alghamdi TH was responsible for study design, collecting data, data analysis, and writing the paper.
Conflict-of-interest statement: Author declares no conflict of interest in publishing the manuscript.
Corresponding author: Thamer H Alghamdi, Associate Professor, Consultant, Department of Surgery, Al-Baha University, King Fahad Street, Al Baha 65716, Saudi Arabia.
Received: October 11, 2025
Revised: December 6, 2025
Accepted: January 27, 2026
Published online: March 24, 2026
Processing time: 170 Days and 19.8 Hours
Revised: December 6, 2025
Accepted: January 27, 2026
Published online: March 24, 2026
Processing time: 170 Days and 19.8 Hours
Core Tip
Core Tip: The importance of this literature review lies in clarifying the timing of surgery and surveillance across divergent consensus statements, highlighting areas of agreement and persistent controversy. Its value lies in distilling and juxtaposing guideline trajectories to expose an implicit hypothesis: That moving from the aggressive approach to the more restrictive, feature-based strategies that reduced unnecessary resections without increasing missed cancers.